LORAZEPAM WITHDRAWAL Help
How to get off lorazepam naturally

LORAZEPAM SIDE EFFECTS MAY INCLUDE*: 

Daytime drowsiness, amnesia or forgetfulness, memory impairment, muscle weakness, lack of balance or coordination, cognitive issues, tiredness, changes in appetite, nausea, diarrhea ,stomach upset, headache, muscle pain, confusion, insomnia, visual changes, memory loss, difficulty concentrating, confusion, hallucinations, slurred speech, agitation, aggressive behavior, anxiety

LORAZEPAM ADVERSE REACTIONS MAY INCLUDE*: per PDR 

Severe: coma, seizures, apnea, suicidal ideation, muscle paralysis, GI bleeding, hearing loss, heart failure, respiratory arrest, cardiac arrest, pneumothorax, pulmonary hypertension, pulmonary edema, pericardial effusion, bradycardia, teratogenesis, neuroleptic malignant syndrome, pancytopenia, lactic acidosis, SIADH, coagulopathy, agranulocytosis, anaphylactoid reactions 

Moderate: hypotension, erytema, delirium, depression, confusion, hypoventilation, ataxia, hallucinations, elevated hepatic enzymes, metabolic acidosis, cystitis, hypertension, tolerance, pscylogical dependence, physiological dependence, amnesia, memory impairment, mania, psychosis, hyper reflexia, euphoria, hostility, dysarthria, impotence, constipation, urinary incontinence, hyper bilirubinemia, blurred vision, jaundice, hypoxia, respiratory depression, sinus tachycardia, withdrawal, myoclonia, hyponatremia, thrombocytopenia  

Mild: injection site reaction, drowsiness, dizziness, weakness, restlessness, headache, tremor, agitation, nausea, vomiting, hyper salivation, hyperventilation, chills, infection, insomnia, nightmares, anxiety, hyperactivity, irritability, asthenia, fatigue, vertigo, libido increase, diarrhea, diplopia, orgasm dysfunction, libido decrease, diaphoresis, hypothermia, alopecia, rash

LORAZEPAM CONTRAINDICATIONS AND PRECAUTIONS*:  per PDR 

Alcoholism, chronic obstructive pulmonary disease (COPD), CNS depression, coadministration with other CNS depressants, congenital heart disease, ethanol intoxication, pulmonary disease, pulmonary hypertension, respiratory depression, respiratory insufficiency, sleep apnea, status asthmaticus 

As with other benzodiazepines, lorazepam should be used with extreme caution in patients with pulmonary disease and in patients with respiratory insufficiency resulting from chronic obstructive pulmonary disease (COPD), status asthmaticus, abnormal airway anatomy, cyanotic congenital heart disease, or pulmonary hypertension. Additionally, avoid coadministration with other CNS depressants, especially opioids, when possible, as this significantly increases the risk for profound sedation, respiratory depression, low blood pressure, and death. Reserve concomitant use of these drugs for patients in whom alternative treatment options are inadequate. If concurrent use is necessary, use the lowest effective doses and minimum treatment durations possible and monitor patients closely for signs and symptoms of respiratory depression and sedation. Lorazepam injection is contraindicated in patients with sleep apnea syndrome or severe respiratory insufficiency who are not receiving mechanical ventilation. Lorazepam can cause respiratory depression, apnea, airway obstruction, and oxygen desaturation; it is more likely to cause adverse respiratory effects when administered to patients with pulmonary conditions, significant CNS depression, or ethanol intoxication. Avoid use of lorazepam in patients with active alcoholism. In addition, hypercarbia and hypoxia can occur after lorazepam administration and may pose a significant risk to patients with congenital heart disease or pulmonary hypertension. Carefully monitor respiratory status and oxygen saturation in at risk patients.*

top of page